Thomas Nee, Principal at Larchmont Ventures, is a portfolio strategist and systems architect who builds repeatable frameworks for growth, adaptation, and scale across healthcare, consumer, and creative markets.
He specializes in company-by-company diagnostics, pilot sequencing, and unified measurement models that help organizations move from fragmented operations to best-in-class performance. His work spans therapeutics, devices, and consumer health, with a focus on designing and piloting agentic AI, creative operations automation, and data-driven decision systems for integration into core operating models.
Currently, he is an Operating Partner at a middle market healthcare private equity firm, where he advises on commercial strategy and research across portfolio companies and investment opportunities. He also serves on the Mid-Atlantic Bio Angels Executive Committee and Screening Committee.
A Gap-Analysis Approach
Thomas’s work is anchored in a three-tier diagnostic lens:
| Dimension | Current State | Standard of Care | Best-in-Class |
|---|---|---|---|
| Healthcare & Therapeutics | Fragmented adoption of data-driven evaluation; siloed asset reviews | Centralized valuation and commercial frameworks by therapeutic area | Scalable diagnostic engines that evaluate hundreds of assets annually with kill/advance gates and unified measurement |
| Devices & Consumer Health | Incremental innovation, limited integration of AI/automation | Established playbooks for market entry and lifecycle management | Adaptive systems designing and piloting agentic AI, creative ops automation, and cross-market benchmarking |
| Consumer Product Commercialization Lab | Reliance on intuition-driven campaigns; high creative fatigue | Modular campaign design with A/B testing | Fully automated commercialization frameworks with scenario modeling, strict auditability, and repeatable conversion engines |
This gap analysis is not just a diagnostic tool—it’s the blueprint Thomas applies across industries to move organizations from fragmented current states toward best-in-class adaptive systems.
Career Foundations
Earlier in his career, Thomas led valuation and commercial strategy across multiple therapeutic areas, including:
- Neurology
- Ophthalmology
- Dermatology / Aesthetics
- Cardiovascular / Metabolic
- Respiratory / Pulmonary
- Oncology (targeted and specialty niches)
- Gastroenterology
He built infrastructures that evaluated hundreds of assets annually and created commercial frameworks that generated multi‑billion‑dollar revenue streams. These experiences became the prototypes for the scalable diagnostic systems he now applies across industries.
Parallel Experiments
Beyond healthcare, Thomas actively experiments in his Consumer Product Commercialization Lab, applying the same diagnostic rigor to modular campaign testing, audience expansion, and conversion-aligned frameworks. These parallel experiments sharpen his ability to prototype, validate, and scale systems in diverse markets.
Forward Vision
Looking ahead, Thomas is focused on:
- Building a scalable, repeatable consumer product commercialization engine anchored in narrative-driven engagement
- Designing and piloting agentic AI, creative operations automation, and data-driven decision systems for integration into healthcare, consumer, and device operating models
- Developing cross-industry frameworks that transform complexity into clarity and uncertainty into advantage
At the core of his work is a single principle: systems that adapt endure. Whether in healthcare, consumer markets, or creative ventures, Thomas designs frameworks that turn diagnostics into durable engines of growth.
Thomas has an MBA from the Stanford Graduate School of Business. He has a BS in Biology, with specializations in Chemistry and Psychology from Santa Clara University.